Press Releases

Press Releases

March 17, 2020
Surface Oncology Announces First Patient Dosed in Clinical Trial of Immuno-Oncology Candidate SRF617
March 10, 2020
Surface Oncology Reports Financial Results and Corporate Highlights for Fourth Quarter and Full Year 2019
February 25, 2020
Surface Oncology to Present at the 40th Annual Cowen Healthcare Conference
January 27, 2020
Surface Oncology Announces FDA Clearance of SRF617 and SRF388 INDs to Initiate Phase 1 Clinical Trials
Displaying 21 - 24 of 24